Takara Bio Europe Introduces GMP-Grade Cellartis® MSC EV Wonder™ to Support Clinical-Scale Extracellular Vesicle Production
October 28, 2026
October 28, 2026
October 22, 2026
August 17, 2026
June 16, 2026
May 18, 2026
May 7, 2026
October 6, 2025
September 30, 2025
December 10, 2024
October 28, 2026
Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing more than 20 years of leadership experience across healthcare and comp...
October 28, 2026
Takara Bio Europe announces the introduction of a Good Manufacturing Practice (GMP)-grade version of Cellartis® MSC EV Wonder™, its defined, xeno-free...
October 27, 2026
WLan-led financing reaches a €25 million first closing, comprising €3 million in new capital and €22 million in shareholder convertible-bond conversio...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225